Search for Merck & Co Inc and
    1. May 19, 2016

      Pull together to prevent a superbug apocalypse

      Jim O’Neill, UK Treasury minister and former Goldman Sachs economist, has focused the world’s attention on...

    2. Fast FT

      May 19, 2016

      Merck KGaA boosted by acquisition in Q1

      Merck KGaA saw a substantial rise in both sales and profits in the first quarter, the first period in which a recent...

    Special Reports

    1. Inventions and Patents

      Over the past 40 years, global R&D has largely been dominated by Europe, the US and Ja...
    2. Special Report: Doing Business in Lyon 2013

      Urban renewal is at the heart of ambitions to rise up the rankings in the economic pre...
    Search more Special Reports on this topic.

    1. May 9, 2016

      Pfizer to trial triple-combination cancer treatment

      Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make...

    2. Fast FT

      May 5, 2016

      Merck raises underlying earnings guidance

      US drugmaker Merck has raised its full year guidance for underlying earnings per share despite sales edging down 1 per...

    3. April 26, 2016

      Tony Coles – on a mission to tackle Alzheimer’s

      After brokering the $10bn sale of the biotech company he led, Tony Coles planned to follow the well-trodden path of...

    4. February 1, 2016

      Finance sector pay shifts from bonuses to salaries, says Mercer survey

      The world’s banks, insurers and investment managers continued to cut staff bonuses last year in favour of increasing...

    5. January 31, 2016

      Gilead risks becoming victim of its own success

      During the past two years, Gilead, a California-based drugmaker, has emerged as the undisputed leader of the four large...

    6. January 29, 2016

      Merck launches hepatitis C drug price war

      Merck has launched a price war in the treatment of hepatitis C by setting the list price of its new drug at a 40 per...

    7. January 25, 2016

      Brexit would be a ‘mistake’, say global pharma leaders

      A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

    8. January 23, 2016

      Why the Disrupted are privately griping about tech upstarts at Davos

      Given the theme of this year’s World Economic Forum was the Fourth Industrial Revolution, it was natural that Silicon...

    9. January 15, 2016

      Merck of Germany wins UK support in battle with US namesake

      Merck of Germany has won the backing of a UK court in its battle with Merck of the US over the family name shared by...

    10. December 15, 2015

      Sanofi/Boehringer: swap shop

      Swapping assets was a form of human trade since long before bankers and their fees arrived on the scene. In...

    11. December 14, 2015

      AstraZeneca: in search of a blockbuster

      Jimmy Carter can tell you why AstraZeneca is contemplating paying $5bn for an unquoted Dutch biotech company with a...

    12. FT Alphaville

      December 4, 2015

      Relypsa: the next US biotech M&A target?

      StreetInsider.com reports: Merck & Co (NYSE: MRK) plans to make a non-binding offer to acquire Relypsa, (Nasdaq: RLYP),...

    13. December 1, 2015

      Eli Lilly and Merck bolstered by upgrades

      Pharmaceutical stocks received a shot in the arm after analysts at Barclays upgraded Eli Lilly and Merck citing...

    14. November 26, 2015

      Unhealthy drugs: Pharma struggles with its reputation

      An industry dedicated to saving and extending lives might be expected to find empathy easy. Instead, some of the...

    15. November 22, 2015

      Pfizer-Allergan tie-up would mark M&A high point

      Pfizer’s imminent $150bn takeover of Allergan to create the world’s biggest drugmaker will mark a fresh pinnacle in an...

    16. November 13, 2015

      Animal health: double or quits

      Sea lice. Fowl pox. Swine fever. Foot-and-mouth. Animal diseases often take prosaic names. This does not make them...

    17. October 12, 2015

      Eli Lilly’s heart-drug setback reverberates through pharma sector

      Shares of several of the US’s largest drugmakers were roiled on Monday after Eli Lilly surprisingly halted development...

    18. October 12, 2015

      Eli Lilly shares sink as it scraps heart drug

      Eli Lilly has pulled the plug on a potential blockbuster medicine intended to ward off heart attacks and strokes,...

    19. October 9, 2015

      Scots nurse ‘serious’ with Ebola after-effects as epidemic fades

      A Scottish nurse suffering the after-effects of Ebola was readmitted to an isolation unit on Friday — highlighting...

    20. September 7, 2015

      Groundbreaking cancer drug given NHS approval

      A groundbreaking new cancer drug that harnesses the immune system to kill tumours has been recommended for use by the...

    21. September 7, 2015

      The hedgefundification of bond funds

      Bill Gross, the bond king-in-exile at Janus Capital, may not have attracted as many investors as he hoped to follow him...

    22. July 31, 2015

      Health experts hail Ebola breakthrough

      Public health experts have hailed a “turning point” in the fight against Ebola, after preliminary results for an...

    23. July 23, 2015

      Volunteers find it hard to put their skills to good use

      LinkedIn made a surprising discovery when it launched an online service for executives wanting to use their skills to...

    24. July 12, 2015

      Drugmakers premiere summer blockbusters

      Blockbuster drugs are back. A wave of new multibillion-dollar medicines for heart disease and high cholesterol, added...

    25. June 11, 2015

      Printing whole organs remains a long way off

      Three dimensional printing is already being used to manufacture everything from simple plastic figurines to complex...

    26. May 31, 2015

      Clinical trials show cancer drug combo boosts survival rate

      A combination of two “immunotherapy” medicines made by Bristol-Myers Squibb can dramatically improve the chances of...

    27. May 15, 2015

      The drugs to watch in fight against cancer

      About 30,000 doctors and scientists will arrive in Chicago in two weeks for the annual meeting of the American Society...

    28. May 5, 2015

      Global spending on cancer drugs surges to $100bn

      Global annual spending on cancer drugs has hit $100bn for the first time as the pharmaceuticals industry prepares to...

    29. May 3, 2015

      A tale of two Mercks: Confusion mounts over shared brand name

      Merck of Germany is to step up investment in its brand to defend the company’s rights to the 347-year-old name it...

    30. April 28, 2015

      Investors sour on Coach turnround efforts

      Investors soured on Coach despite its turnround efforts after the retailer reported fiscal third-quarter results that...

    31. April 28, 2015

      Pfizer cuts forecasts as strong dollar bites

      Pfizer on Tuesday became the latest US drugmaker to warn a strengthening dollar was hurting its performance as it cut...

    32. April 20, 2015

      Bristol-Myers combination melanoma treatment shows promise

      Skin cancer patients taking two Bristol-Myers Squibb drugs that help their immune systems fight melanoma saw their...

    33. April 8, 2015

      Biosimilar drugs: spot the difference

      Big pharma groups crushed by patent expirations in the first decade of this century spent the second rushing into...

    34. February 6, 2015

      Investor flows reignite corporate bond issuance

      A pick-up in investor flows into mutual funds and ETFs investing in bonds in the past couple of weeks is encouraging...

    35. February 4, 2015

      Merck defends children’s vaccines after measles outbreak

      Merck has launched a staunch defence of its childhood vaccines, after an outbreak of measles in California prompted a...

    36. February 2, 2015

      Big pharmaceuticals groups faces biosimilars challenge

      Global pharmaceuticals companies have seen an improvement in their drugs pipelines but the industry is facing a fresh...

    37. January 23, 2015

      GSK ships Ebola vaccine to west Africa

      GlaxoSmithKline has shipped the first batch of its experimental Ebola vaccine to west Africa for clinical trials even...

    38. January 16, 2015

      J&J receives €100m EU injection for Ebola vaccine development

      Johnson & Johnson is to receive more than €100m from the EU to accelerate development of its experimental Ebola vaccine...

    Search for Merck & Co Inc and